Skip to main content

Table 3 The final glucose homeostasis parameters in the five study groups

From: Reversion to regular diet with alternate day fasting can cure grade-I non-alcoholic fatty liver disease (NAFLD) in high-fructose-intake-associated metabolic syndrome

  Insulin (ng/ml) HOMA-IR HbA1C (mg/dl)
C 0.13±0.01 (9) 1.09±0.10 (9) 5.97±0.30 (10)
MS 0.91±0.06a (10) 7.35±0.83a (10) 6.60±0.39 (14)
MSRD 0.61 ±0.07a,b (9) 4.67 ±0.55a,b (9) 6.08±0.52(12)
MSF 0.64±0.07 a,b (9) 4.46 ±0.52 a,b (9) 5.25±0.11b (13)
MSRDF 0.39 ±0.05a,b,c,d (9) 2.29±0.35b,c,d (9) 5.23±0.16b (12)
  1. C, control group, MS, untreated metabolic syndrome group, MSRD, metabolic syndrome group reverted to regular rat chow, MSF, metabolic syndrome group on alternate day fasting, MSRDF, metabolic syndrome group reverted to regular rat chow and on alternate day fasting; HOMA-IR, homeostasis model assessment of insulin resistance; HbA1C, glycosylated hemoglobin
  2. Data are expressed as mean ± SEM
  3. In the parenthesis is the number of observations
  4. a: Significance from control group, by LSD test at P ≤0.05
  5. b: Significance from MS group, by LSD test at P ≤0.05
  6. c: Significance from MSRD group, by LSD test at P ≤0.05
  7. d: Significance from MSF group, by LSD test at P ≤0.05